HR 6575
115th Congress
House
Health
Administrative remedies
Congressional oversight
Department of Health and Human Services
Government studies and investigations
Health care coverage and access
Medicare
Prescription drugs
Public contracts and procurement
Medicare Prescription Drug Savings and Choice Act of 2018
Introduced: July 26, 2018
Introduced by:
Schakowsky, Janice D.
Democratic
· Illinois
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 13, 2018
Referred to the Subcommittee on Health.
Jul 27, 2018
Referred to the Subcommittee on Health.
Jul 26, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 26, 2018
Introduced in House
Plain-English summary
Medicare Prescription Drug Savings and Choice Act of 2018
This bill requires the Centers for Medicare & Medicaid Services (CMS) to offer one or more Medicare-operated prescription drug plan options under the Medicare prescription drug benefit. In doing so, the CMS must: (1) negotiate prices with drug manufacturers; (2) establish an appeals process for denials of plan benefits, including the option for external review and determination by an independent entity; and (3) establish and apply a formulary and formulary incentives. In general, a Medicare-operated drug plan must meet the same requirements as apply to any other prescription drug plan.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4